Eli Lilly Posts Better-than-Expected Earnings for Q3 (Reuters)
Drug maker Eli Lilly and Co. reported better-than-expected third-quarter earnings today. The Indianapolis, Ind.-based Lilly earned $1.2 billion ($1.11 per share) in Q3, compared to $1.33 billion ($1.18 per share) in the previous year, beating analysts’ expectations slightly. Lilly’s shares closed the day at $50.15, up from the previous day’s close of $49.65. Earnings were powered by growth in the company’s drugs for depression, diabetes and cancer, in addition to cost-cutting measures. Lilly investors should expect to see similar returns in Q4.
Seven tips to day-trade with a signal could put people on a profitable path if…
Over the past two weeks, investors have been on the receiving end of several key…
Do you know what inflation and the recent college protests have in common? They’re the…
When looking to invest in the S&P 500, SPX and SPY options are similar assets…
An index option is a contract that gives the buyer the right, but not the…
“There’s more wisdom in your book than four years of college education!” -- Subscriber Back…